Utility of the Plasma Level of suPAR in Monitoring Risk of Mortality during TB Treatment

OBJECTIVE: To investigate whether changes in the plasma level of soluble urokinase plasminogen activator receptor (suPAR) can be used to monitor tuberculosis (TB) treatment efficacy. DESIGN: This prospective cohort study included 278 patients diagnosed with active pulmonary TB and followed throughou...

Descripción completa

Detalles Bibliográficos
Autores principales: Rabna, Paulo, Andersen, Andreas, Wejse, Christian, Oliveira, Ines, Gomes, Victor Francisco, Haaland, Maya Bonde, Aaby, Peter, Eugen-Olsen, Jesper
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3429420/
https://www.ncbi.nlm.nih.gov/pubmed/22937128
http://dx.doi.org/10.1371/journal.pone.0043933

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3429420/
https://www.ncbi.nlm.nih.gov/pubmed/22937128
http://dx.doi.org/10.1371/journal.pone.0043933

Ejemplares similares